Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study. Issue 11 (November 2018)

• Record Type: Journal Article
• Authors: Lorimier, Gérard; Seegers, Valérie; Coudert, Marie; Dupoiron, Denis; Thibaudeau, Emilie; Pouplin, Luc; Lebrec, Nathalie; Dubois, Pierre Yves; Dumont, Frédéric; Guérin-Meyer, Véronique; Capitain, Olivier; Campone, Mario; Wernert, Romuald
• Is Part Of: European journal of surgical oncology. Volume 44:Issue 11(2018)
• Page Start: 1824
• Page End: 1831
• Publication Date: 2018-11
• Subjects: Colorectal cancer -- Peritoneal metastases -- Cytoreductive surgery -- HIPEC -- Epidural analgesia; Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2018.08.012
• Languages: English
• ISSNs: 0748-7983

Abstract

Abstract: Objective: To assess the effectiveness of prolonged perioperative thoracic epidural analgesia (PEA) on long term survival of patients who underwent a complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases (CPM). Background: Grade III-IV morbidity affects long term outcomes after CRS and HIPEC. As compared with opioid administered via patient-controlled analgesia (PCA), PEA reduces morbidity. Method: From 2005 to 2016, 150 patients underwent CRS plus HIPEC with or without prolonged PEA. Clinical data and outcomes collected from prospective database were analyzed. Survival was assessed in terms of analgesic method using Kaplan-Meier plots and a propensity score. Results: Patients 'characteristics of 59 patients in PCA group were comparable to those of 91 patients in PEA group, except for age, ASA score and fluid requirements, significantly more important in PEA group. Grade III-IV morbidity was 62.7% in PCA group compared with 36.3% in PEA group ( p = 0 . 0015) . Median overall survival (OS) of PEA group was 54.7 months compared to 39.5 months in PCA group ( p = 0 . 0078) . When adjusted on the covariates, using the propensity score, the PEA significantly improves OS [HR 0.40 (95% CI: 0.28–0.56)] ( p < 0 . 0001 ) and disease free survival (DFS) [HR 0.61 (95% CI: 0.45–0.81] ( p < 0 . 0007 ) Conclusions: In this retrospective study of patients who underwent a complete CRS and HIPEC for colorectal peritoneal metastases, the perioperative thoracic epidural analgesia prolonged for over 72 h reduced significantly the grade III-IV morbidity and may improve OS and DFS.